Ankle tendon tears involve partial or complete rupture of the tendons that connect muscles to bones in the ankle. These tendons are crucial for stabilizing the ankle, absorbing impact, and facilitating movement. The most commonly affected tendons in the ankle are the Achilles tendon, peroneal tendons, and posterior tibial tendon.
ORTHOReNEW powered by Regenexx USA provides cutting-edge, non-surgical regenerative therapies for ankle tendon tears, aimed at promoting natural healing and functional recovery. Their approach utilizes advanced biologic treatments, including Super Concentrated Platelets (SCP), Bone Marrow Concentrate (BMC), and Prolotherapy, which are designed to repair and strengthen damaged tendons without the need for invasive surgery.
Procedures using Regenexx-SD injectate include a patented protocol that utilizes Bone Marrow Concentrate (BMC), which contains the patient’s own mesenchymal stem cells. The cell processing for a Regenexx-SD injectate routinely achieves 20x concentration— above what non-Regenexx cell processing can achieve.
Procedures using Regenexx-SCP injectate represent a supercharged version of platelet-rich plasma (PRP). In this process, blood is drawn, then processed to isolate the platelets and growth factors. The growth factors are then purified, concentrated, and injected into the hip area using imaging guidance for precision. Regenexx-SCP injectate provides a higher concentration of growth factors than typical PRP procedures.